COVID-19 Resources for Patients and Families

A single-dose of the antiviral drug peginterferon lambda reduced by half the risk of hospitalization or a visit to the Emergency Department due to COVID-19.

According to the new Ontario Ministry of Health guidelines Evusheld is no longer recommended due to the prevalence of circulating variants resistant to Evusheld in Ontario.

A summary of information about Paxlovid. Topics include what the medication is used for, when it should not be used, what are the ingredients, and what may interact with this medication.

Paxlovid fact sheet covering how to use it, what to do if you forget a dose, common side effects and who should not take it.

How does Paxlovid work, who will have access and how much will it cost in Canada.

UHN infectious diseases specialists Dr. Susy Hota and Dr. Isaac Bogoch talk about how people might be able to access the new COVID-19 antiviral pill, Paxlovid, and how it could impact the health-care system.

Topics include what the medication is used for, warnings and precautions, possible interactions and who should or should not use this medication.

A Canadian study suggests the antiviral medication remdesivir could have a “modest but significant effect” on COVID-19 patient outcomes, including decreasing the need for mechanical ventilation by approximately 50 per cent.

Remdesivir is recommended in moderately ill hospitalized patients with COVID-19 requiring supplemental oxygen.

Medication used to treat patients who are hospitalized with COVID-19. Common side effects and what you should tell your health care provider before receiving the medication.